Compugen Ltd. - Ordinary Shares (CGEN): Price and Financial Metrics

Compugen Ltd. - Ordinary Shares (CGEN): $1.97

0.11 (+5.91%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add CGEN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#29 of 347

in industry

CGEN Price/Volume Stats

Current price $1.97 52-week high $3.03
Prev. close $1.86 52-week low $0.53
Day low $1.83 Volume 406,400
Day high $1.98 Avg. volume 541,064
50-day MA $2.07 Dividend yield N/A
200-day MA $1.69 Market Cap 170.65M

CGEN Stock Price Chart Interactive Chart >


Compugen Ltd. - Ordinary Shares (CGEN) Company Bio


Compugen Ltd. engages in the research, development, and commercialization of therapeutic and product candidates primarily in the United States, Europe, and Israel. The company was founded in 1993 and is headquartered in Tel Aviv, Israel.


CGEN Latest News Stream


Event/Time News Detail
Loading, please wait...

CGEN Latest Social Stream


Loading social stream, please wait...

View Full CGEN Social Stream

Latest CGEN News From Around the Web

Below are the latest news stories about COMPUGEN LTD that investors may wish to consider to help them evaluate CGEN as an investment opportunity.

Biotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More

Compugen (CGEN) and Moderna (MRNA) are in the news on collaboration and study updates, respectively.

Yahoo | December 21, 2023

Gilead (GILD), Compugen Collaborate for Immunotherapy Program

Gilead (GILD) enters into a license agreement with Compugen for its pre-clinical immunotherapy program.

Yahoo | December 20, 2023

Compugen (NASDAQ:CGEN) delivers shareholders impressive 144% return over 1 year, surging 158% in the last week alone

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you pick the right...

Yahoo | December 20, 2023

Why Are Stocks Up Today?

Stocks are up today and investors wondering why will want to keep reading as we have a breakdown of the market's rally on Tuesday!

William White on InvestorPlace | December 19, 2023

Why Is Compugen (CGEN) Stock Up 189% Today?

Compugen stock is up on Tuesday as investors in CGEN shares react to an exclusive licensing agreement with Gilead Sciences.

William White on InvestorPlace | December 19, 2023

Read More 'CGEN' Stories Here

CGEN Price Returns

1-mo -19.26%
3-mo -22.13%
6-mo 14.53%
1-year 95.05%
3-year -76.74%
5-year -49.74%
YTD -0.51%
2023 176.65%
2022 -83.36%
2021 -64.49%
2020 103.19%
2019 174.65%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!